FDA Grants Breakthrough Device Designation to Castle Biosciences’ DecisionDx®-Melanoma Test

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. PCG
2. NVDA
3. ALNY
4. CNS
5. AVGO
6. APO
7. ATTO
8. BRVE
9. OKE
10. SRE

Go back to FDA Grants Breakthrough Device Designation to Castle Biosciences’ DecisionDx®-Melanoma Test
Castle Technologies, Inc. (NASDAQ: CSTL) Delayed: 33.50 --0 (-0%)
Previous Close $33.50    52 Week High $3.92 
Open $33.50    52 Week Low $0.00 
Day High $33.50    P/E N/A 
Day Low $33.50    EPS $0.00 
Volume 521       

Castle Technologies, Inc. (NASDAQ: CSTL) Delayed: 33.50 --0 (-0%)
Previous Close $33.50    52 Week High $3.92 
Open $33.50    52 Week Low $0.00 
Day High $33.50    P/E N/A 
Day Low $33.50    EPS $0.00 
Volume 521